Science is a clinical-stage technology company developing biohybrid neural interfaces and advanced neural recording electronics to address serious unmet medical needs in neuroscience. Their technologies aim to enhance neural communication and restore vision, facilitating new treatment possibilities for patients with neurological disorders.
Funding
$186M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+61Founders
Product
Problem
Neurological disorders and vision impairment present significant unmet medical needs, often requiring invasive procedures and specialized equipment for neural communication and vision restoration. Current treatments may lack the precision and biocompatibility needed for long-term efficacy and integration with neural tissues.
Solution
Science Corp is developing biohybrid neural interfaces and advanced neural recording electronics to address these challenges. Their approach combines biological and synthetic components to create interfaces that can seamlessly integrate with the nervous system. These technologies aim to enhance neural communication and restore vision by providing a more natural and effective way to interact with neural tissues. The company's vertically integrated approach allows them to develop a full range of technologies, from advanced neural recording electronics to laser projection optics, needed for next-generation neural interfaces.
Target Audience
The primary target audience includes patients with neurological disorders and vision impairment, as well as clinicians and researchers seeking advanced tools for neural communication and vision restoration.
Features
- Biohybrid neural interfaces designed for seamless integration with neural tissues
- Advanced neural recording electronics for high-resolution data acquisition
- Laser projection optics for precise stimulation and imaging of neural activity
- Vertically integrated technology development, covering the full range of components needed for neural interfaces
- Clinical-stage development focused on addressing serious unmet medical needs in neuroscience